Copyright Reports & Markets. All rights reserved.

Global Endometriosis Therapies Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Endometriosis Therapies Market Overview

      • 1.1 Product Overview and Scope of Endometriosis Therapies
      • 1.2 Endometriosis Therapies Segment by Type
        • 1.2.1 Global Endometriosis Therapies Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Hormonal Contraceptives
        • 1.2.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists
        • 1.2.4 Progestin Therapy
        • 1.2.5 Aromatase Inhibitors
      • 1.3 Endometriosis Therapies Segment by Application
        • 1.3.1 Endometriosis Therapies Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.4 Global Endometriosis Therapies Market by Region
        • 1.4.1 Global Endometriosis Therapies Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Endometriosis Therapies Market Size
        • 1.5.1 Global Endometriosis Therapies Revenue (2014-2025)
        • 1.5.2 Global Endometriosis Therapies Production (2014-2025)

      2 Global Endometriosis Therapies Market Competition by Manufacturers

      • 2.1 Global Endometriosis Therapies Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Endometriosis Therapies Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Endometriosis Therapies Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Endometriosis Therapies Production Sites, Area Served, Product Types
      • 2.5 Endometriosis Therapies Market Competitive Situation and Trends
        • 2.5.1 Endometriosis Therapies Market Concentration Rate
        • 2.5.2 Endometriosis Therapies Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Endometriosis Therapies Production Market Share by Regions

      • 3.1 Global Endometriosis Therapies Production Market Share by Regions
      • 3.2 Global Endometriosis Therapies Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Endometriosis Therapies Production
        • 3.4.1 North America Endometriosis Therapies Production Growth Rate (2014-2019)
        • 3.4.2 North America Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Endometriosis Therapies Production
        • 3.5.1 Europe Endometriosis Therapies Production Growth Rate (2014-2019)
        • 3.5.2 Europe Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Endometriosis Therapies Production (2014-2019)
        • 3.6.1 China Endometriosis Therapies Production Growth Rate (2014-2019)
        • 3.6.2 China Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Endometriosis Therapies Production (2014-2019)
        • 3.7.1 Japan Endometriosis Therapies Production Growth Rate (2014-2019)
        • 3.7.2 Japan Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Endometriosis Therapies Consumption by Regions

      • 4.1 Global Endometriosis Therapies Consumption by Regions
      • 4.2 North America Endometriosis Therapies Consumption (2014-2019)
      • 4.3 Europe Endometriosis Therapies Consumption (2014-2019)
      • 4.4 China Endometriosis Therapies Consumption (2014-2019)
      • 4.5 Japan Endometriosis Therapies Consumption (2014-2019)

      5 Global Endometriosis Therapies Production, Revenue, Price Trend by Type

      • 5.1 Global Endometriosis Therapies Production Market Share by Type (2014-2019)
      • 5.2 Global Endometriosis Therapies Revenue Market Share by Type (2014-2019)
      • 5.3 Global Endometriosis Therapies Price by Type (2014-2019)
      • 5.4 Global Endometriosis Therapies Production Growth by Type (2014-2019)

      6 Global Endometriosis Therapies Market Analysis by Applications

      • 6.1 Global Endometriosis Therapies Consumption Market Share by Application (2014-2019)
      • 6.2 Global Endometriosis Therapies Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Endometriosis Therapies Business

      • 7.1 AbbVie
        • 7.1.1 AbbVie Endometriosis Therapies Production Sites and Area Served
        • 7.1.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.1.3 AbbVie Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Eli Lilly
        • 7.2.1 Eli Lilly Endometriosis Therapies Production Sites and Area Served
        • 7.2.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.2.3 Eli Lilly Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 AstraZeneca
        • 7.3.1 AstraZeneca Endometriosis Therapies Production Sites and Area Served
        • 7.3.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.3.3 AstraZeneca Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Bayer
        • 7.4.1 Bayer Endometriosis Therapies Production Sites and Area Served
        • 7.4.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.4.3 Bayer Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Astellas Pharma
        • 7.5.1 Astellas Pharma Endometriosis Therapies Production Sites and Area Served
        • 7.5.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.5.3 Astellas Pharma Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Meditrina Pharmaceuticals
        • 7.6.1 Meditrina Pharmaceuticals Endometriosis Therapies Production Sites and Area Served
        • 7.6.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Pfizer
        • 7.7.1 Pfizer Endometriosis Therapies Production Sites and Area Served
        • 7.7.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.7.3 Pfizer Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Neurocrine Biosciences
        • 7.8.1 Neurocrine Biosciences Endometriosis Therapies Production Sites and Area Served
        • 7.8.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.8.3 Neurocrine Biosciences Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Takeda Pharmaceutical
        • 7.9.1 Takeda Pharmaceutical Endometriosis Therapies Production Sites and Area Served
        • 7.9.2 Endometriosis Therapies Product Introduction, Application and Specification
        • 7.9.3 Takeda Pharmaceutical Endometriosis Therapies Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Endometriosis Therapies Manufacturing Cost Analysis

      • 8.1 Endometriosis Therapies Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Endometriosis Therapies
      • 8.4 Endometriosis Therapies Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Endometriosis Therapies Distributors List
      • 9.3 Endometriosis Therapies Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Endometriosis Therapies Market Forecast

      • 11.1 Global Endometriosis Therapies Production, Revenue Forecast
        • 11.1.1 Global Endometriosis Therapies Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Endometriosis Therapies Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Endometriosis Therapies Price and Trend Forecast (2019-2025)
      • 11.2 Global Endometriosis Therapies Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Endometriosis Therapies Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Endometriosis Therapies Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Endometriosis Therapies Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Endometriosis Therapies Production, Revenue Forecast (2019-2025)
      • 11.3 Global Endometriosis Therapies Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Endometriosis Therapies Consumption Forecast (2019-2025)
        • 11.3.2 Europe Endometriosis Therapies Consumption Forecast (2019-2025)
        • 11.3.3 China Endometriosis Therapies Consumption Forecast (2019-2025)
        • 11.3.4 Japan Endometriosis Therapies Consumption Forecast (2019-2025)
      • 11.4 Global Endometriosis Therapies Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Endometriosis Therapies Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month

        The global Endometriosis Therapies market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Endometriosis Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis Therapies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        AbbVie
        Eli Lilly
        AstraZeneca
        Bayer
        Astellas Pharma
        Meditrina Pharmaceuticals
        Pfizer
        Neurocrine Biosciences
        Takeda Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Hormonal Contraceptives
        Gonadotropin-releasing Hormone (Gn-RH) Agonists 
        Progestin Therapy
        Aromatase Inhibitors

        Segment by Application
        Hospital
        Clinic
        Other

        Buy now